v3.26.1
Stock Options and Restricted Stock Units (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Stock Options and Restricted Stock Units [Abstract]    
Schedule of Company’s Stock Options

A summary of the status of the Company’s stock options as of March 31, 2026 and December 31, 2025, and changes during the periods then ended are presented below:

 

Options

 

Wtd. Avg.
Exercise
Price

Balance, January 1, 2025

 

417,003

 

 

$

7.00

Granted during the period

 

60,000

 

 

 

3.00

Exercised during the period

 

 

 

 

Terminated/Expired during the period

 

(51,300

)

 

 

10.57

Balance, December 31, 2025

 

425,703

 

 

$

6.01

Granted during the period

 

 

 

 

Exercised during the period

 

 

 

 

Terminated/Expired during the period

 

(30,250

)

 

 

13.90

Balance, March 31, 2026

 

395,453

 

 

$

5.40

     

 

 

 

 

Exercisable at March 31, 2026

 

380,453

 

 

$

5.50

A summary of the status of the Company’s stock options as of December 31, 2025 and 2024, and changes during the years then ended are presented below.

 

Options

 

Wtd. Avg.
Exercise
Price

Balance, January 1, 2024

 

461,870

 

 

$

8.34

Granted during the period

 

80,000

 

 

 

3.75

Exercised during the period

 

(15,229

)

 

 

3.45

Terminated/Expired during the period

 

(109,638

)

 

 

9.86

Balance, December 31, 2024

 

417,003

 

 

$

7.00

Granted during the period

 

60,000

 

 

 

3.00

Exercised during the period

 

 

 

 

Terminated/Expired during the period

 

(51,300

)

 

 

10.57

Balance, December 31, 2025

 

425,703

 

 

$

6.01

     

 

 

 

 

Exercisable at December 31, 2025

 

395,703

 

 

$

6.23

Schedule of Summarizes Information About Outstanding Stock Options

The following table summarizes information about outstanding stock options at March 31, 2026:

Range of Exercise Price

 

Number
Outstanding

 

Wtd. Avg,
Life

 

Wtd. Avg.
Exercise
Price

$3.00 – $23.80

 

395,453

 

2.4 Years

 

$

5.50

The following table summarizes information about outstanding stock options at December 31, 2025:

Range of Exercise Price

 

Number
Outstanding

 

Wtd. Avg,
Life

 

Wtd. Avg.
Exercise
Price

$3.00 – $23.80

 

425,703

 

2.5 Years

 

$

6.01

The following table summarizes information about outstanding stock options at December 31, 2025:

Range of Exercise Price

 

Number
Outstanding

 

Wtd.Avg,
Life

 

Wtd. Avg.
Exercise
Price

$3.00 – $23.80

 

425,703

 

2.5 years

 

$

6.01

Schedule of Company’s RSUs

A summary of the status of the Company’s RSUs as of March 31, 2026, is presented below.

 

Number of
Units

 

Wtd. Avg.
Grant Date
Fair
Value per
Unit

Unvested units as of January 1, 2025

 

282,628

 

 

$

6.06

Granted during the period

 

3,000

 

 

 

Vested during the period

 

(95,210

)

 

 

Forfeited during the period

 

(2,000

)

 

 

Unvested Units as of December 31, 2025

 

188,418

 

 

$

6.06

Granted during the period

 

243,172

 

 

 

3.19

Vested during the period but shares not issued

 

(243,172

)

 

 

3.19

Forfeited during the period

 

 

 

 

Unvested Units as of March 31, 2026

 

188,418

 

 

$

6.06

     

 

 

 

 

Vested as of March 31, 2026

 

338,382

 

 

$

4.00

A summary of the status of the Company’s RSUs as of December 31, 2025 is presented below:

 

Number of
Units

 

Weighted
Average
Grant
Date Fair
Value
per Unit

Unvested Units at January 1, 2024

 

 

 

$

Granted during the period

 

282,628

 

 

 

6.06

Vested during the period

 

 

 

 

Terminated/Forfeited during the period

 

 

 

 

Unvested Units at December 31, 2024

 

282,628

 

 

$

6.06

Granted during the period

 

3,000

 

 

 

6.06

Vested during the period

 

(95,210

)

 

 

6.06

Terminated/Forfeited during the period

 

(2,000

)

 

 

6.06

Unvested Units at December 31, 2025

 

188,418

 

 

$

6.06

     

 

 

 

 

Vested Units at December 31, 2025

 

 

 

$

Schedule of Stock Options Granted  

The fair values of stock options granted were estimated using the Black-Sholes option-pricing model with the following assumptions for the years ended December 31:

 

2025

 

2024

Risk-free interest rates

 

 

3.8

%

 

 

3.8

%

Expected life (in years)

 

 

2.6

 

 

 

2.7

 

Expected volatility

 

 

76.52

%

 

 

64.00

%

Dividend yield

 

 

0

%

 

 

0

%

   

 

 

 

 

 

 

 

Weighted-average grant date fair value per share

 

$

3.00

 

 

$

3.75